SCHEMBL7057566

SCHEMBL7057566

CN1CCCC(Oc2cccc([N+](=O)[O-])c2)CC1

nearest known ligand 0.57

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CHRNB4 P30926 4/20 0.57
CHRNA3 P32297 4/20 0.57
SLC6A2 P23975 1/20 0.55
SLC6A4 P31645 1/20 0.55
SLC6A3 Q01959 1/20 0.55
CHRNB2 P17787 3/20 0.47
CHRNA4 P43681 2/20 0.47
FAAH O00519 4/20 0.46
PKM P14618 1/20 0.46
LTA4H P09960 1/20 0.45
PTGS2 P35354 1/20 0.45
CHRNB1 P11230 1/20 0.44
CHRNB3 Q05901 1/20 0.44
LMNA P02545 1/20 0.42
HIF1A Q16665 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL374672 0.95 SLC6A2 (0.60) CHRNB4CHRNA3SLC6A2SLC6A4SLC6A3
SCHEMBL25335598 0.88 SLC6A2 (0.59) CHRNB4CHRNA3SLC6A2SLC6A4SLC6A3
SCHEMBL25336072 0.87 SLC6A2 (0.57) CHRNB4CHRNA3SLC6A2SLC6A4SLC6A3
SCHEMBL25336074 0.86 SLC6A2 (0.56) CHRNB4CHRNA3SLC6A2SLC6A4SLC6A3
SCHEMBL18956784 0.85 SLC6A2 (0.68) CHRNB4CHRNA3SLC6A2SLC6A4SLC6A3
SCHEMBL12894408 0.85 SLC6A2 (0.68) CHRNB4CHRNA3SLC6A2SLC6A4SLC6A3
SCHEMBL15054178 0.84 SLC6A2 (0.66) CHRNB4CHRNA3SLC6A2SLC6A4SLC6A3
SCHEMBL31518364 0.84 SLC6A2 (0.66) CHRNB4CHRNA3SLC6A2SLC6A4SLC6A3
SCHEMBL19878954 0.82 SLC6A2 (0.71) CHRNB4CHRNA3SLC6A2SLC6A4SLC6A3
SCHEMBL29739455 0.82 SLC6A2 (0.71) CHRNB4CHRNA3SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003026666-A1 2-PHENYLAMINO-4- (5-PYRAZOLYLAMINO)-PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS, IN PARTICULAR, AS SRC KINASE INHIBITORS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed